Merge PACS vs EchoNext
AI Verdict
Choose Merge PACS if…
Choose Merge PACS if your health system requires an enterprise-level solution for consolidating imaging data, streamlining radiology workflows across multiple sites, and integrating various AI insights into a single worklist. It is ideal for organizations seeking flexible deployment options (on-premise, cloud, hybrid) and robust features for multi-modality diagnostic interpretation, including advanced mammography tools and real-time analytics.
View Merge PACS →Choose EchoNext if…
Choose EchoNext if your clinical practice or hospital aims to enhance early detection of hidden structural heart disease, such as heart failure, valve disease, and pulmonary hypertension, using standard ECGs. This FDA-cleared AI tool is particularly well-suited for broad access, from major hospitals to community practices, and integrates with clinical decision support platforms like OpenEvidence to provide non-invasive diagnostic support at the point of care.
View EchoNext →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Merge PACS | EchoNext |
|---|---|---|
| Pricing | Contact vendor | Starts at $600/month |
| Deployment | On-premise, Cloud, Hybrid | Available through the OpenEvidence clinical decision support platform. |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Yes AI-estimated | Yes AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Merge PACSMerge PACS emphasizes a comprehensive and customizable user experience for radiology and enterprise imaging, with features like dynamic worklist refresh, fewer clicks for mammography reading, and a unified platform across departments. EchoNext, while integrated into a clinical decision support platform, focuses on a specific diagnostic task, and its general usability beyond that integration isn't as extensively detailed.
Clinical Value
EchoNextEchoNext has demonstrated superior clinical value through multiple validation studies where its AI model outperformed cardiologists in detecting structural heart disease from ECGs. It has also been credited with leading to the first AI-triggered heart transplant, showcasing a direct impact on patient outcomes. Merge PACS offers AI integration and enhanced diagnostic workflows, but specific comparative clinical outcome data against human interpretation or other tools are not provided in the same detail.
Pricing & Value
EchoNextEchoNext offers transparent tiered pricing starting at $600/month, with clear details on implementation fees and annual discounts. Merge PACS requires contacting the vendor for pricing, which suggests less transparency and potentially higher, more variable costs associated with an enterprise-level PACS. EchoNext's clear pricing structure provides better upfront value understanding.
Enterprise Readiness
Merge PACSMerge PACS is explicitly designed as an enterprise-level PACS, offering multi-site support, flexible deployment (on-premise, cloud, hybrid), integration with various healthcare systems (EMR/EHR, RIS, HIS, VNA), and robust security. EchoNext is available through a clinical decision support platform and targets a broad range of practices, but its enterprise-wide deployment and integration capabilities are not as extensively detailed as Merge PACS.
Innovation
EchoNextEchoNext represents a significant innovation as the world's first FDA-cleared AI tool to detect hidden structural heart disease from standard ECGs, a capability that has been shown to outperform human cardiologists. Merge PACS focuses on integrating third-party AI and enhancing existing PACS workflows, which is valuable but not as groundbreaking in terms of novel diagnostic capability.
Support & Docs
Merge PACSMerge PACS, as an established enterprise solution, offers comprehensive support through a community hub, direct phone lines (North America, Australia, Global), webinars, and product documentation. While EchoNext is integrated into the OpenEvidence platform, specific details about its direct support and documentation are not as readily available.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Merge PACS | EchoNext |
|---|---|---|
| Tool Name | Merge PACS | EchoNext |
| Company | Merative | Pathway Labs |
| Description | An enterprise-level Picture Archiving and Communication System (PACS) that streamlines radiology workflows, consolidates imaging data, and integrates AI insights across multi-site health systems. It supports multi-modality diagnostic interpretation with flexible deployment options. | An FDA-cleared AI tool that analyzes standard ECGs to detect hidden structural heart disease, including heart failure, valve disease, and pulmonary hypertension. |
| Categories | Cardiology AI, Radiology & Imaging AI | Cardiology AI, Clinical Decision Support & Reference, Lab & Diagnostics |
| Specialties | Cardiology, Radiology | Cardiology, Family Medicine, Hospital Medicine, Internal Medicine |
| Key Features (Examples) | AI integration and readiness, Customizable, composite worklist, Cloud-ready architecture | AI-powered ECG analysis, Detection of hidden structural heart disease, Identifies heart failure risk |
Videos
Demos, reviews, and walkthroughs featuring Merge PACS and EchoNext.